Galectin-9 Regulates Monosodium Urate Crystal-Induced Gouty Inflammation Through the Modulation of Treg/Th17 Ratio.

Galectin-9 Regulates Monosodium Urate Crystal-Induced Gouty Inflammation Through the Modulation of Treg/Th17 Ratio.
复制标题

DOI:
10.3389/fimmu.2021.762016
复制
发表时间:
2021
影响因子:
7.3
通讯作者:
Iqbal AJ
Iqbal AJ
中科院分区:
医学2区
文献类型:
--
作者:
Mansour AA;Raucci F;Saviano A;Tull S;Maione F;Iqbal AJ

文献摘要

参考文献

被引文献

相似文献

Gout is caused by depositing monosodium urate (MSU) crystals within the articular area. The infiltration of neutrophils and monocytes drives the initial inflammatory response followed by lymphocytes. Interestingly, emerging evidence supports the view that in situ imbalance of T helper 17 cells (Th17)/regulatory T cells (Treg) impacts the subsequent damage to target tissues. Galectin-9 (Gal-9) is a modulator of innate and adaptive immunity with both pro- and anti-inflammatory functions, dependent upon its expression and cellular location. However, the specific cellular and molecular mechanisms by which Gal-9 modulates the inflammatory response in the onset and progression of gouty arthritis has yet to be elucidated. In this study, we sought to comprehensively characterise the functional role of exogenous Gal-9 in an in vivo model of MSU crystal-induced gouty inflammation by monitoring in situ neutrophils, monocytes and Th17/Treg recruited phenotypes and related cyto-chemokines profile. Treatment with Gal-9 revealed a dose-dependent reduction in joint inflammation scores, knee joint oedema and expression of different pro-inflammatory cyto-chemokines. Furthermore, flow cytometry analysis highlighted a significant modulation of infiltrating inflammatory monocytes (CD11b+/CD115+/LY6-Chi) and Th17 (CD4+/IL-17+)/Treg (CD4+/CD25+/FOXP-3+) cells following Gal-9 treatment. Collectively the results presented in this study indicate that the administration of Gal-9 could provide a new therapeutic strategy for preventing tissue damage in gouty arthritic inflammation and, possibly, in other inflammatory-based diseases.
DOI: 10.1016/j.jare.2017.04.008
发表时间: 2017-09
影响因子: 10.7
作者:
Ragab G;Elshahaly M;Bardin T
通讯作者: Bardin T
DOI: 10.1186/ar2952
发表时间: 2010
影响因子: 4.9
作者:
Busso N;So A
通讯作者: So A
Tim-3/galectin-9 通路参与刀豆球蛋白 A 诱导的肝炎小鼠模型中肝脏 Tregs 的稳态。
DOI: 10.1016/j.molimm.2013.11.001
发表时间: 2014-03-01
影响因子: 3.6
作者:
Ju, Ying;Shang, Xuming;Zou, Jianwen
通讯作者: Zou, Jianwen
DOI: 10.1038/ncomms8464
发表时间: 2015-06-25
影响因子: 16.6
作者:
Akitsu A;Ishigame H;Kakuta S;Chung SH;Ikeda S;Shimizu K;Kubo S;Liu Y;Umemura M;Matsuzaki G;Yoshikai Y;Saijo S;Iwakura Y
通讯作者: Iwakura Y
DOI: 10.1186/s13075-020-02158-3
发表时间: 2020-04-15
影响因子: 4.9
作者:
Fujita, Yuya;Asano, Tomoyuki;Migita, Kiyoshi
通讯作者: Migita, Kiyoshi